The United States Food and Drug Administration (USFDA) has completed inspection at SMS Lifesciences India’s API manufacturing facility located at Sy. No. 180/2, Kazipally, Jinnaram Mandal, Sangareddy district, Telangana (Unit I), without any observations. The inspection commenced on April 4, 2022 and concluded on April 8, 2022.
SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.
